- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services
TAKE Limited's Board approved the re-appointment of Director Parmeshvar Dhangare and appointed M/s. A. Raghavendra Rao & Associates as Statutory Auditors for 5 years. The 25th Annual General Meeting (AGM) is scheduled for September 29, 2026, for shareholder approvals, with e-voting from September 26-28.
TAKE Limited delivered strong Q1 FY27 results: consolidated revenue hit ₹30.37 Cr and net profit reached ₹1.06 Cr, reversing prior-year losses. The company is strategically expanding into Biohacking, Nutraceuticals, and Digital Longevity Solutions, targeting high-margin, recurring revenue.
TAKE Ltd's board approved Q1 FY27 results. Consolidated revenue hit ₹30.37 Cr, with Net Profit at ₹1.06 Cr, a turnaround from loss. The company strategically entered the Longevity, Biohacking, and Preventive Healthcare market. Finance costs plummeted to ₹0.07 Lakhs.